NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.
Spontaneous CD4(+) T-cell responses to the tumor-specific antigen NY-ESO-1 (ESO) are frequently found in patients with epithelial ovarian cancer (EOC). If these responses are of effector or/and Treg type, however, has remained unclear. Here, we have used functional approaches together with recently...
Main Authors: | Nassima Redjimi, Karine Duperrier-Amouriaux, Isabelle Raimbaud, Immanuel Luescher, Danijel Dojcinovic, Jean-Marc Classe, Dominique Berton-Rigaud, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, Danila Valmori, Maha Ayyoub |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21829534/?tool=EBI |
Similar Items
-
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.
by: Ahmed Hamaï, et al.
Published: (2011-01-01) -
ANALYSIS, ISOLATION AND ACTIVATION OF ANTIGEN-SPECIFIC CD4+ AND CD8+ T CELLS BY SOLUBLE MHC-PEPTIDE COMPLEXES
by: Julien eSchmidt, et al.
Published: (2013-07-01) -
Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity.
by: Kanako Saito, et al.
Published: (2015-01-01) -
Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
by: Danila Valmori, et al.
Published: (2004-11-01) -
Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells
by: Oscar L Haigh, et al.
Published: (2020-07-01)